A Study of RG-012 in Subjects With Alport Syndrome

NCT03373786 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Genzyme, a Sanofi Company